Skip to main content
Fig. 1 | BMC Veterinary Research

Fig. 1

From: Impact of a combination of pimobendan, furosemide, and enalapril on heart rate variability in naturally occurring, symptomatic, myxomatous mitral valve degeneration dogs

Fig. 1

Scatter plots representing the distribution of (A) left ventricular internal diastole diameter normalized to body weight (LVIDDN), (B) left atrial-to-aortic root ratio (LA/Ao), (C) shortening fraction (SF), (D) vertebral heart score (VHS), (E) systolic blood pressure (SBP), and (F) heart rate (HR) including the median and interquartile range of each parameter in dogs with MMVD stage C at the baseline and after treatment with a combination of pimobendan, furosemide, and enalapril at 1 (M1), 3 (M3), and 6 (M6) months; the central horizontal bar in each column represents the median. The error bars represent the 1st and 3rd quartiles. *indicates P < 0.05 when compared with baseline value

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us